Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-04-05

Posted on April 5, 2024July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-04-05

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Electronics reported provisional Q1 2024 consolidated revenue of approximately KRW 71.00T and operating profit of KRW 6.60T, up 11.37% and 931.25% year-on-year, respectively.

📊 [Summary of Key Disclosure Details & Figures]

  • Performance Category: Q1 2024 (Provisional Consolidated Financial Results)
  • Q1 2024 Performance:
    • Revenue: KRW 71.00T / +4.75% QoQ / +11.37% YoY
    • Operating Profit: KRW 6.60T / +134.04% QoQ / +931.25% YoY
    • Profit Before Income Tax: Not stated (-)
    • Net Profit: Not stated (-)
    • Net Profit Attributable to Controlling Interests: Not stated (-)
  • Cumulative Performance (Q1 2024):
    • Cumulative Revenue: KRW 71.00T / +11.37% YoY
    • Cumulative Operating Profit: KRW 6.60T / +931.25% YoY
    • Cumulative Profit Before Income Tax: Not stated (-)
    • Cumulative Net Profit: Not stated (-)
    • Cumulative Net Profit Attributable to Controlling Interests: Not stated (-)
  • Other Important Matters:
    • Figures are preliminary results prior to external accounting review and are subject to change
    • The company plans to re-disclose performance details upon Board of Directors approval for Q1 2024 results

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Re-disclosure and Final Audited Results

Since these figures are preliminary sales results released prior to review completion, checking the subsequent re-disclosure upon board approval and final figures is important to verify the accurate performance tally. Related details can be verified in upcoming re-disclosures and periodic reports (Quarterly Reports).

📢 Disclaimer & Source Notice

Source: This content was structured and regenerated based on official filings submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided strictly for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK Hynix (000660) – Other Management Decisions (Voluntary Disclosure) / 2024-04-04
Next Post: [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Holding Announcement / 2024-04-05

Related Posts

[Disclosure] ALTEOGEN (196170) – Temporary Postponement of KOSPI Relisting / 2026-07-16 Disclosures
[Disclosure] Hana Micron (067310) – Exercise of Conversion Right / 2024-03-15 Semiconductors
[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-04-28 Disclosures
[Disclosure] Celltrion (068270) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-09-23 Disclosures
[Disclosure] Hanwha Aerospace (012450) – Notice of Investor Relations (IR) Event (4Q 2023 Earnings Release Conference Call & Webcast) Disclosures
[Disclosure] Hanwha Systems (272210) Changes Head Office Address Following Completion of New Headquarters Building Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme